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ABSTRACT Innovative tools are essential for advancing malaria control and depend on an understanding of
molecular mechanisms governing transmission of malaria parasites by Anophelesmosquitoes. CRISPR/Cas9-
based gene disruption is a powerful method to uncover underlying biology of vector-pathogen interactions
and can itself form the basis of mosquito control strategies. However, embryo injection methods used to
genetically manipulate mosquitoes (especially Anopheles) are difficult and inefficient, particularly for non-
specialist laboratories. Here, we adapted the ReMOT Control (Receptor-mediated Ovary Transduction of
Cargo) technique to deliver Cas9 ribonucleoprotein complex to adult mosquito ovaries, generating targeted
and heritable mutations in the malaria vector Anopheles stephensi without injecting embryos. In Anopheles,
ReMOT Control gene editing was as efficient as standard embryo injections. The application of ReMOT
Control to Anopheles opens the power of CRISPR/Cas9 methods to malaria laboratories that lack the
equipment or expertise to perform embryo injections and establishes the flexibility of ReMOT Control for
diverse mosquito species.
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To solve the growing problem of mosquito-borne disease, we need
improved and more efficient gene editing methods. Targeted disrup-
tion of genes in mosquito vectors of human pathogens is a powerful
method to uncover the underlying biology of mosquito pathogen
transmission that can inform the development and application of new
approaches to mosquito and disease control (Dong et al. 2018; Ling
and Raikhel 2018; Duvall et al. 2019; Raji et al. 2019; Matthews et al.
2019). Genome manipulation technologies can themselves form the
basis of mosquito and pathogen control strategies (Kyrou et al. 2018;
Binh Pham et al. 2019). While many techniques based on CRISPR/
Cas9 have improved studies in mosquito genetics, these techniques
rely on embryo injection of the Cas9 ribonucleo-protein complex
(RNP), which requires specialized and expensive equipment and
training. To get around this bottleneck, a strategy termed ReMOT
Control (Receptor-Mediated Ovary Transduction of Cargo) was
developed for delivery of gene-editing moieties to the arthropod
germline from the hemocoel, allowing targeted and heritable muta-
tions to be made by adult injection instead of embryo microinjection
(Chaverra-Rodriguez et al. 2018). Proof-of-principle experiments
validating ReMOT Control were conducted in Aedes aegypti, but
extension of the method to species more recalcitrant to editing (such
as Anopheles mosquitoes) was not established.
In this study, we have adapted the ReMOT Control technique
for efficient gene editing in Anopheles stephensi a major vector of
Plasmodium parasites in India and Southeast Asia and so a major
object for malaria research. A transgenic line of An. stephensi con-
taining two fluorescent markers was already being used to establish
protocols Cas9-mediated gene editing and so this line provided a
straight-forward first target for ReMOT Control in Anopheles. We
found that once optimized, gene editing by ReMOT Control in
Anophelesmosquitoes was comparable to the technique in Ae. aegypti
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and as efficient in editing as standard embryo injections. As Anoph-
elines are substantially more difficult to manipulate at the embryo
stage than Aedes mosquitoes, ReMOT Control represents a much-
needed improvement in gene editing for malaria vectors. We expect
that with ReMOT Control gene editing will become as commonly
used for reverse genetics in Anophelesmosquitoes as it has become in
Aedine vectors of human arboviruses.
MATERIALS AND METHODS
Mosquitoes
Anopheles stephensi wild type (Liston strain) and the Anopheles
stephensi transgenic line VgCp26.10 (AP26) were reared at 27,
75 6 10% relative humidity, 12h light: 12h dark in a walk-in
environmental chamber. Larvae were fed with a slurry of 1:2 by
volume Tetramin:baker’s yeast. Adults were provided ad libitum
with 10% sterilized sugar on a cotton ball. For injection experi-
ments female mosquitoes were fed on anonymous human blood
(Biospecialty Corp.) using a water-jacketed membrane feeding
system.
Embryo microinjections
Anopheles stephensi females from a homozygous transgenic line
VgCp26.10 (Binh Pham et al. 2019) were used to generate hetero-
zygous embryos for injection. Blood-fed An. stephensi mosquitoes
were induced to lay eggs 3-5 days after a blood meal by combining
6-10 females in a narrow Drosophila vial with cotton and Whatman
filter paper wet with isotonic buffer (150mMNaCl, 5mM KCl; 10mM
HEPES; 2.5mM CaCl2; pH 7.2). At approximately 1 hr and 15 min
after laying, a paintbrush was used to transfer embryos that were
sufficiently melanized to a small piece of filter paper wet with isotonic
buffer. Under a dissecting scope, the outer membrane was removed
with jeweler’s forceps from the embryos and embryos were aligned
with posterior poles to the left while maintaining moisture on the
paper. After alignment of 30-70 embryos, the paper was dried briefly,
embryos were transferred to toupee tape on a plastic cover slip and
an oil mixture (1:1 Halocarbon 700 oil: Halocarbon 27 oil) was used
to cover the embryos to prevent further desiccation. Quartz needles
were pulled using a Sutter P2000 needle puller and were used with
a Femtojet injector (Eppendorf) and InjectMan micromanipula-
tor. Following injection, oil was removed from embryos with a
Kim Wipe and embryos were submerged on the tape into a petri
dish with isotonic buffer and transferred back to an insectary to
hatch. Hatching was monitored daily for 14 days and hatched larvae
were immediately transferred to a pan with food. The injection
mix from successful experiments comprised 200ng/uL Streptococcus
pyogenes Cas9 (PacBio) and 100ng/mL each of three single guide
RNAs initially described for use to target green fluorescent protein
(EGFP) in human cell (12, Table S4). Injected embryos (generation 0,
G0) that survived to adulthood were outcrossed: families comprised
five G0 males allowed to mate individually to 10 wild-type females
each for 2 days, then combined and pools comprised age-matched
G0 females batch mated to wild-type males. G1 progeny resulting
from families and pools were screened for both red and cyan
fluorescence in the eyes.
Adult injections
Adult females with ages ranging from 5 to 22 days old were blood-fed
using a glass water jacketed membrane feeder. The next day, females
were immobilized by incubation at 4 until motionless, then placed
on ice and sorted. Females with visible blood-meals were injected
intrathoracically using a glass needle drawn from a glass capillary
(World Precision Instruments) using a needle puller (Sutter P2000)
and aspirator assembly (A5177, Sigma) until we could observe visible
distention of the abdomen, diuresis or liquid emerging from the
injection site (approximately 200 nl).
Adult injection mix preparation
P2C-Cas9 and P2C-EGFP proteins were expressed from pET28a-
P2C-Cas9 and pRSET-P2C-EGFP respectively by recombinant
BL21 E.coli (NEB) as described previously in detail (Chaverra-
Rodriguez et al. 2018). Single guide RNAs (sgRNAs) were prepared
using a PCR template amplified by CRISPR_F primers designed
for each ECFP target and CRISPR_R primers (Table S4). In vitro
transcription was used to produce sgRNAs from PCR template
using either MegaScript T7 or MegaScript RNAi kits with at least
1000ng of PCR template. Two to four volumes of the in vitro
transcription reaction were required to achieve the high quantities
of guide RNA required for adult injections. In addition to P2C-Cas9
and sgRNAs, saponin was included in some injection mixes. Saponin
dilutions were prepared fresh prior to each injection from dry crude
extract of Quillaja bark containing .20% saponin (Sigma-Aldrich).
All concentrations of saponin reported here represent concentration
of crude extract.
The final step in P2C-Cas9 expression and purification from
transformed Escherichia coli is dialysis of the protein in a pH 8.0
buffer consisting 50 mM Tris-HCl pH 8.0, 200 mM KCl, 0.1 mM
EDTA, 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 1mM
dithiothrietol (DTT). Injections using this buffer produced a high
mortality in An. stephensi females, but we found that concentrated
stocks of P2C-Cas9 protein often precipitated when water, 1X PBS or
guide RNA solutions were added to the protein solution. However,
if the P2C-Cas9 protein was diluted in a large volume (300-500mL) of
50 mMTris-HCl pH 8.0, 200 mMKCl and small volumes (,20mL)
of highly concentrated (3-10 mg/mL) sgRNA were added and
allowed to complex, the buffer of the RNP could then be exchanged
with 1X PBS using an Amicon 10K filter column, which retains the
large protein and both bound and unbound guide RNA. Following
buffer exchange, saponin, water and additional sgRNA were added
to produce solutions of 0.5-0.75 mg/mL P2C-Cas9, 0.75-1.2 mg/mL of
total guide RNA (from a premixed solution of the three sgECFPs),
50 mg/L saponin extract from Quillaja bark and less than 5 mM
residual KCl.
Larval screening
G0 and G1 larvae were screened at larval instar stage 3 or 4. Larvae
were immobilized by applying larvae to a wet filter paper in a BÜchner
funnel attached to vacuum filtering flask. Larvae were kept slightly
wet during screening under UV fluorescence microscopy with a Leica
dissecting scope or Zeiss Axiozoom.
Imaging
To determine the optimal time for P2C-mediated delivery, adult
females were injected with P2C-EGFP (Chaverra-Rodriguez et al.
2018) 24 hr before and 4, 24, and 48 hr after a bloodmeal. Adult
female ovaries were dissected 72 hr post-blood meal, mounted on a
slide in SlowFade Gold Antifade Mountant (Invitrogen) between
two double layers of scotch tape to prevent the ovaries from being
squashed by the plastic coverslip. The coverslip was sealed in place
using nail polish on the edges of the slip and ovaries were visualized
on Olympus BX41. All images were captured using 311ms exposure
for 200X and 1030ms exposure for 40X images.
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Molecular analysis of mutant individuals
Mutant G0 and G1 mosquitoes identified by visual screening were
collected individually and G1 progeny frommutant G0 were collected
in groups of five individuals, frozen and stored at -20. Genomic
DNA was extracted using Wizard Genomic DNA Purification Kit
or Qiagen DNeasy Blood & Tissue kits following the protocol for
extraction of DNA from animal tissues. Genomic DNA was used as a
template for PCR using the NEB Phusion enzyme and using primers
against the transgenes and surrounding DNA (Figures 3A, S4).
Diagnostic gel bands were extracted using Zymoclean Gel DNA
Recovery kit (Zymo, Irvine) cloned into pJet1.2/blunt using the
CloneJET PCR Cloning Kit (ThermoFisher) and sequenced. Se-
quence analyses were performed using the DNAstar Lasergene suite.
Data availability
All data are described in the text and/or included in tables and figures
within the manuscript and in the supplement uploaded into figshare
as follows:
Figure S1: Alignment of amplicon sequences from PCR B validate
the presence of the transgene in 17 ECFP knockout individuals. Table
S1: Results from screening single G0 male families (1,2,3 etc.) and
pools (Px) of G0 females injected as embryos with 200 ng/mL Cas9
and three sgRNAs targeting ECFP (300ng/mL total). Table S2: Results
from screening single G0 male families (1,2,3 etc.) and Pools (PX) of
G0 females injected as embryos with 200 ng/mL Cas9 and three
sgRNAs targeting ECFP (total 75ng/mL). Table S3: Summary of
injection components used for G0 embryo injections and resulting
gene-editing detected in G1. Table S4: Primers used for current study.
Supplemental material available at figshare: https://doi.org/10.25387/
g3.11827914.
RESULTS AND DISCUSSION
ECFP targeting, mutation detection scheme, and
validation by embryo microinjection
To establish a method for site-specific editing in An. stephensi, we
used ReMOT Control to target one of the two fluorescent marker
genes in the transgenic An. stephensi line VgCp26.10 (Binh Pham
et al. 2019), which offered several advantages for establishment of
mutagenesis methods over the endogenous eye color genes previously
used. The gene encoding kynurenine 5-monooxygenase (kmo or
kynurenine hydroxylase, kh) was used as a visible marker to develop
both embryo injection and adult injection methods in Ae. aegypti
(Basu et al. 2015; Chaverra-Rodriguez et al. 2018). However, the kmo
knockout is associated with substantially decreased fitness in An.
stephensi, while the VgCp26.10 transgenic line is robust and is not
likely to suffer from the phenotypic loss of a fluorescent marker
(Gantz et al. 2015; Binh Pham et al. 2019). A mutation in the one
dominant visible fluorescent marker gene (enhanced cyan fluores-
cence protein, ECFP) is easy to detect in hemizygous live mosquitoes
by fluorescence imaging while simultaneous expression of the intact
linked marker gene (Discosoma species Red, DsRed) confirms pres-
ence of the transgene rather than the wild-type empty locus (Li and
Handler 2019).
Initial validation of targeted knockdown of ECFP in the
VgCp26.10 transgenic line by embryo microinjection provided a
benchmark to assess ReMOT Control knockout efficiency. Homo-
zygous transgenic embryos (generation 0, G0) were injected with Cas9
plasmid expression cassette, mRNA, or protein, and three single
guide RNAs originally designed to target EGFP in human cells (Zhang
et al. 2014) but which also cut ECFP due to a high degree of sequence
conservation between the two genes. Surviving G0 embryos injected
with 200 ng/mL Cas9 protein and 300 ng/mL sgRNAs produced
G1 offspring lacking cyan fluorescence in the eyes but expressing
DsRed in four out of 32 single male G1 families and one female
pool, resulting in frequencies of 12.5% families producing edited
offspring and 1.5–24% of G1 offspring edited within those families
(Table 1 and Table S1). ECFP knockout individuals comprised 1.5%
of total G1 screened across all families. Two male families produced
individuals with loss of both cyan and red fluorescence, indicating
that a modification occurred that not only interrupted ECFP expres-
sion, but also interrupted expression of the DsRed marker that was
over 7 kilobases away (Figure 1B). Such large deletions are not
unprecedented, but are likely under-reported in studies where PCR
amplicons of limited size are used to detect deletions (Kosicki et al.
2018). Injection of embryos with a reduced concentration of total
gRNA (75ng/mL) produced fewer visually detectible mutations; G1
individuals with ECFP disruption were only identified from one pool
of females out of 11 total female pools and single male families and
constituted 0.13% of G1 individuals screened (Tables S1 and S2).
No knock-outs were detectable in G1 larvae when G0 embryos were
injected with 500 ng/mL of Cas9 transcript or 500 ng/mL of plasmid
with Cas9 expressed from the Hsp70 promoter (pDCC6, Gokcezade
et al. 2014) (Table S3).
Optimization of injection components for adult injection
In order to accomplish heritable mutagenesis in An. stephensi by
ReMOT Control, we utilized the ovary targeting P2C peptide derived
from Drosophila melanogaster yolk protein 1 (DmYP1), which we
recently reported in Ae. aegypti to mediate delivery of Cas9 RNP into
vitellogenic oocytes (Chaverra-Rodriguez et al. 2018). However, we
found that the Aedes injection parameters were not directly trans-
latable to An. stephensi. Timing of injection of the P2C-Cas9 RNP
relative to a blood-meal was reported to impact the developmental
stage at which genome modifications are made in Ae. aegypti.
Additionally, An. stephensi have lower tolerance in general to injected
components. We identified the injection conditions and timing that
would maximize RNP uptake into the ovaries in a way that balanced
survival and egg laying with concentrations of RNP effective for
editing. We first injected females with P2C-EGFP fusion protein and
visualized uptake into the ovary by fluorescence microscopy (Figure
2A). Green fluorescence was more intense and present in all oocytes
dissected from injected females when P2C-EGFP was injected within
two days of blood feeding compared to decreased fluorescence when
the protein was injected prior to a blood meal. Only 50% of ovary
pairs had visible fluorescence in females injected 48 hr after a blood
meal, perhaps because injected females were past the peak of vitel-
logenesis (Nirmala et al. 2006; Isaacs et al. 2011) but those with visible
fluorescence were comparable in intensity to earlier injections. Thus,
experimental injections were performed within the first two days of a
blood meal.
In previous work, we used chloroquine to facilitate exit of the Cas9
RNP from the endosome after uptake, but previous work in the field
of drug delivery has demonstrated that saponins (Quallaja bark
extract) act as potent endosomal escape reagents and ongoing work
in our lab optimizing ReMOT Control for Aedes suggested that
it might be as or more effective (Fuchs et al. 2009; Gilabert-Oriol
2014). For Anopheles ReMOT editing, we therefore investigated
the use of saponin for endosome escape. In order to identify the
highest concentration of saponin that would result in survival and
viable offspring of injected adults, we performed a set of prelimi-
nary injections using different concentrations of the extract in 1X
Volume 10 April 2020 | ReMOT Control in Anopheles stephensi | 1355
n
■
Ta
b
le
1
In
je
ct
io
n
d
at
a
an
d
co
m
p
ar
is
o
n
o
f
E
C
FP
m
ut
at
io
n
b
y
ad
ul
t
an
d
em
b
ry
o
in
je
ct
io
ns
In
je
ct
io
n
M
ix
G
-1
G
0
Fl
uo
re
sc
en
ce
Ph
en
ot
yp
e
G
1
Fl
uo
re
sc
en
ce
Ph
en
ot
yp
e
Pr
ot
ei
n
sg
EC
FP
Sa
p
on
in
G
-1
C
ro
ss
N
o.
In
je
ct
ed
In
je
ct
io
n
tim
e
PB
M
(h
ou
rs
)
N
o.
on
EC
d
ay
N
o.
C
ya
n+
C
ya
n-
C
ya
n-
C
ya
n
M
os
ai
c
G
0
C
+
R+
O
ut
cr
os
s
N
o.
C
ya
n+
C
ya
n-
C
ya
n-
D
sR
ed
+
D
sR
ed
-
D
sR
ed
+
D
sR
ed
+
D
sR
ed
+
D
sR
ed
-
D
sR
ed
+
A
d
ul
t
in
je
ct
io
ns
:
P
2C
-C
as
9/
g
R
N
A
m
ix
in
je
ct
io
ns
in
to
V
g
C
p
26
.1
0
co
lo
ny
fe
m
al
es
(G
-1
)
cr
o
ss
ed
w
it
h
w
ild
ty
p
e
m
al
es
0.
5
m
g
/m
L
0.
75
m
g
/m
L
+
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
30
0
24
21
2
42
5
10
6
31
7
2
(0
.4
7%
)
0
Fe
m
al
e
29
5
10
3
19
2
0
M
al
e
62
2
32
4
29
8
0
0.
75
m
g
/m
L
1.
2
m
g
/m
L
+
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
83
48
60
19
4
16
0
24
10
(5
.2
%
)
1
(1
.2
%
)
Fe
m
al
e
52
26
26
0
M
al
e
10
2
38
53
11
(1
0.
8%
)
0.
75
m
g
/m
L
1.
2
m
g
/m
L
+
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
63
47
33
16
1
52
10
7
2
(1
.2
%
)
1

(0
.6
2%
)
Fe
m
al
e
61
29
32
0
M
al
e
84
35
49
0
0.
75
m
g
/m
L
1.
2
m
g
/m
L
+
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
78
46
46
71
41
30
0
2

(2
.8
%
)
Fe
m
al
e
11
3
30
83
0
M
al
e
N
D
Sa
p
+
To
ta
ls
:
52
4
35
1
85
1
35
9
47
8
14
(1
.7
%
)
4
(0
.4
7%
)
13
29
58
5
73
3
11
(0
.8
2%
)
0.
75
m
g
/m
L
1.
1
m
g
/m
L
—
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
97
28
78
18
4
11
4
70
0
0
Fe
m
al
e
21
7
96
11
8
3
(1
.4
%
)
M
al
e
97
49
48
0
0.
75
m
g
/m
L
1.
1
m
g
/m
L
—
V
g
C
p
26
.1
0
Fe
m
al
es
X
W
T
M
al
es
71
25
43
17
3
61
11
2
0
0
Fe
m
al
e
41
15
26
0
M
al
e
20
7
10
9
98
0
Sa
p
-
To
ta
ls
:
16
8
12
1
35
7
17
5
18
2
0
0
56
2
26
9
29
0
3
(0
.5
3%
)
To
ta
ls
:
69
2
47
2
12
08
53
4
66
0
0
0
18
91
85
4
10
23
14
(0
.7
4%
)
E
m
b
ry
o
in
je
ct
io
ns
:
C
as
9/
g
R
N
A
m
ix
in
je
ct
io
ns
in
to
ho
m
o
zy
g
o
us
V
g
C
p
26
.1
0
tr
an
sg
en
ic
em
b
ry
o
s
(G
0
)
0.
2
m
g
/m
L
0.
07
5
m
g
/m
L
—
V
g
C
p
26
.1
0
In
te
rc
ro
ss
30
9
N
ot
Sc
re
en
ed
23
20
23
17
3
(0
.1
3%
)
0
0.
2
m
g
/m
L
0.
3
m
g
/m
L
—
V
g
C
p
26
.1
0
In
te
rc
ro
ss
38
2
N
ot
Sc
re
en
ed
56
46
55
06
52
(0
.9
2%
)
88
(1
.5
%
)
To
ta
ls
:
69
1
79
66
78
23
55
(0
.6
9%
)
88
(1
.1
%
)

in
d
iv
id
ua
lh
ad
on
e
cy
an
+
ey
e
an
d
on
e
cy
an
-
ey
e.

th
es
e
in
d
iv
id
ua
ls
ha
d
m
ar
ke
d
ly
re
d
uc
ed
cy
an
fl
uo
re
sc
en
ce
.
1356 | V. M. Macias et al.
phosphate-buffered saline (PBS, Figure 2B and C). Injection itself
caused substantial decrease in survival and egg laying, but a con-
centration of 50 mg/L saponin could be injected and still have a high
enough oviposition and hatch rate to have enough G0 progeny to
screen. Importantly, we also determined that An. stephensi adults
could not tolerate the dialysis buffer, which is used in the last step of
purification of P2C-Cas9 from E. coli (and which was the buffer used
for injections in Ae. aegypti). P2C-Cas9 precipitated out of solution
when diluted in water or 1X PBS. We found that the buffer of P2C-
Cas9 in complex with sgRNA did not precipitate and so could be
column exchanged with water resulting in a final neutral injection
solution with less than 5uM KCl remaining from the dialysis buffer,
and that was tolerated by injected adults.
ECFP marker knockout by ReMOT Control
P2C-Cas9 RNP with ECFP guide RNAs sgECFP 1, 2 and 3 were
injected along with saponin (50 mg/L) into VgCp26.10 adult females
(G-1) crossed to wild-type males, such that G0 and G1 progeny with
parental phenotypes are either positive for both ECFP and DsRed,
or wild-type. Expected mutant phenotypes from successful editing
would be ECFP-, DsRed+. We recovered ECFP-, DsRed+ G0 indi-
viduals from three out of the four injection groups in which saponin
was included, with a total of twelve ECFP-, DsRed + individuals out of
851 total G0 screened (1.4%). No mutant individuals were recovered
from the G0 progeny in injections without saponin. The VgCp26.10
colony was not completely homozygous at the generation of adult
injection, resulting in wild-type G0, so the efficiency of editing is more
accurately understood in terms of number of alleles edited rather than
the number of individuals. In this case a total of 377 transgenic alleles
were available for editing in the G0 progeny of saponin/P2C-Cas9
RNP injected G-1 females as visually detected by DsRed fluorescence
in heterozygous G1 individuals and 14 (3.7%) were edited, whereas
0% of the 534 alleles were edited in the G0 progeny of G-1 females
injected without saponin. This adjustment is relevant to the extension
of this technique to the mutation of endogenous mosquito genes that
will be present in two copies. In these applications, especially for
genes that lack a visible phenotype, editing is sufficiently efficient to
be able to screen for these mutants by PCR-based methods.
ECFP-, DsRed+ individuals that survived to adulthood were in-
dividually outcrossed to wild-type mosquitoes resulting in G1 progeny,
Figure 1 Schematic of knock-down approach. A) Schematic representation of transgene present in transgenic line VgCp26.10. The transgene has
an ECFP and DsRed marker genes. Three guide RNAs (sgECFP) target Cas9 to the ECFP gene. B) Representative fluorescence image of larvae
showing parental wild-type, parental transgenic and exceptional Cyan-, DsRed+ phenotypes. C) Schematic comparison of embryo and adult
injection approaches for ECFP knock-out and detection of mutants. The shaded box represents not done. Abbreviations are bp: base pair(s), pBac
L/R: piggyBac left/right arm, SV40: simian virus 40 39 untranslated region, DsRed: Discosoma species Red, ECFP: enhanced cyan fluorescent
protein, sgECFP: single guide RNAs against ECFP, KO: knock-out, Gx: generation X.
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of which approximately half were ECFP-,DsRed+ and half were wild-
type, consistent with Mendelian segregation of a transgenic chro-
mosome and a non-transgenic chromosome (Χ2 = 0.0397, P = 0.84)
along with one transgenic mutant and one wild-type. We conclude
from this that ECFP knockouts detected at G0 are complete knockouts
and likely occurred as Cas9 cleavage of the DNA in the oocyte prior to
embryogenesis (Table 2). Four G0 progeny were designated mosaics.
One of these was ECFP positive in only one eye and the three others
had markedly decreased ECFP fluorescence, which is unexpected in
individuals with a transgene at a fixed location (Table 1). Individuals
mosaic for mutation in a targeted gene is expected in G0, as the P2C-
Cas9 editing complex can be active at different stages of development.
In studies targeting the KMO gene for mutation, this manifests in
patchy or pink color in the eyes instead of black eyes (Gantz et al.
2015). In our case, from the presence of fluorescence in only one eye,
we infer that editing at an early enough stage of development that a
distinct pattern of fluorescence loss is seen. Conversely, in individuals
with markedly decreased fluorescence, we speculate that ECFP was
knocked out in some cells of the eye and not in others. We were not
initially screening for mosaicism in ECFP expression, so it is likely
that mosaic presence of ECFP mutations in G0 is more prevalent.
The presence of mosaicism in G0 progeny from adults injected with
RNP demonstrates that, as in analogous experiments in Ae. aegypti,
the complex is delivered to the G-1 ovaries, but in some cases is not
immediately active, but becomes active following initiation of embryo
development. G0 Individuals identified as mosaics were outcrossed
but produced no progeny.
ECFP+, DsRed+ individuals, which are parental in phenotype,
were retained from each injection group, separated by sex and then
out-crossed en masse to wild-type mosquitoes to test for the presence
of germline mutations in the germline ECFP coding sequence. Wild-
type G0 were excluded from further crosses. ECFP-, DsRed+ G1
Figure 2 Optimization of injection components. A) Fluorescent and bright-field imaging of 72 hr (h) post-blood meal (PBM) ovaries following
injection of P2C-EGFP at 1 day (d) before and 4 hr, 1 day and 2 days post-bloodmeal. Scale Bar represents 1mm in 40X images and 100uM in 200X
images. B) Survival measurement following adult injections with different concentrations of Quillaja bark extract. C) Eggs and hatching counts from
eggs laid by females injected with different concentrations of Saponin from Quillaja bark for endosome disruption. Percentages above bars
represent the percentage hatching from eggs laid. Abbreviations are the same as Figure 1 and h: hour, N: number ovary pairs, pre-BM: before blood
meal, PBS: phosphate buffered saline.
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offspring were recovered from one male outcross from a saponin
injection group and one female outcross from a saponin negative
injection group, 0.82% and 0.53% of total G1 from each group
respectively. The presence of ECFP-, DsRed+ progeny from ECFP+,
DsRed+ G0 mosquitoes likely represent editing of the G0 germline
without visible editing of the somatic tissues.
A panel of four primer pairs was used to characterize ECFP-,
DsRed+ modifications (Figure 3A). Two primer sets amplify across
the genomicDNA and the left and right piggyBac arms of the transgene
and so validate the presence of the transgene at the 26.10 locus.
Similarly, a PCR amplicon using a primer set across the transgene
insertion site indicates the presence of a wild-type chromosome at
that locus. A primer set designed to amplify 984 bp across the ECFP
open reading frame and all three sgRNA target sites diagnosed the
mutation character at this site: out of the 19 ECFP- knockout
individuals that were molecularly characterized, only two produced
diagnostic bands with ECFP primers and sequencing of the ampli-
cons revealed small indels (Figure 3B second panel, Figure 3C and
Figure S1). In 17 cases, PCR and sequencing further confirmed the
presence of the transgene at the original locus, but no diagnostic
band was seen from the ECFP open reading frame (Figure 3B third
panel, Figure S1). In one of these, no diagnostic band was seen for
amplification of either the ECFP open reading frame or the left arm,
but the right arm was validated as intact, indicating a disruption of at
least 1600 nucleotides of sequence (Figure 3B fourth panel). These
results suggest that large deletions commonly occurred using ReMOT
Control, similar to results observed from embryo injection of the
same components.
Altogether, we demonstrate with these experiments that heritable
targeted knockouts can be achieved by ReMOT Control in An.
stephensi, and that targeted editing occurs both before and after
embryogenesis as evidenced both by the presence of mosaics in the
G0 progeny and the recovery of ECFP-,DsRed+ G1 individuals
from ECFP+,DsRed+ G0 outcrosses. Compared to embryo injection,
ReMOT Control will allow non-specialist laboratories to conduct
n■ Table 2 G1 progeny from Cyan negative G0 demonstrate
knockouts are heritable
G0 Cross
G1 Fluorescence Phenotype
No.
Cyan+ Cyan- Cyan-
DsRed+ DsRed- DsRed+
C-R+ G0 Male #1 X WT Females 246 0 123 123
C-R+ G0 Male #2 X WT Females 163 0 86 77
C-R+ G0 Male #3 X WT Females 275 0 141 134
C-R+ G0 Male #5 X WT Females 119 0 58 61
C-R+ G0 Male #6 X WT Females 339 0 170 169
C-R+ G0 Male #9 X WT Females 116 0 56 60
Figure 3 Molecular characterization of
ECFP negative G0 and G1 reveals both
small and large deletions. A) Schematic
of PCR strategy for mutant genotype
characterization. Left and Right Primer
sets produce amplicons of 422 and
299 base pairs, respectively, that con-
firm the presence of the transgene
at the 26.10 genomic location. ECFP
amplicon, 984 bp, spans all three target
sites. Primers against genomic DNA
(orange and green arrows) produce a
471bp diagnostic band from a non-
transgenic chromosome. B) Represen-
tative gel images from individuals with
intact transgene on both chromosomes
(first panel), diagnostic amplicons for
both transgenic and wild-type chromo-
some (second panel), amplicons diag-
nostic for a deletion that interrupts
the primer binding site for ECFP am-
plification (third panel) and amplicons
diagnostic for a deletion that interrupts
primer sites for the ECFP amplicon and
the Left amplicon (fourth panel). C)
Alignments of small deletion mutants
from both embryo and adult injections
to ECFP. Abbreviations are the same
as Figure 1 and WT: wild-type, C: cyan,
R: Red, PAM: protospacer motif.
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gene editing experiments in Anopheles mosquitoes and increase the
number of reverse genetic studies in this malaria vector. The trans-
lation of ReMOT Control from Ae. aegypti to An. stephensi mosqui-
toes required modifications of the injection parameters, including
timing, concentrations, and endosome escape strategies. The use of
saponin dramatically increased the efficiency of knockout, consistent
with results of analogous injections of the endosomal escape reagent
chloroquine in the application of ReMOT Control to Ae. aegypti. It is
possible that many reagents that mediate endosomal escape are usable
for ReMOT control, which will further the adaptability of this tech-
nique. The ligand P2C is broadly effective in mosquitoes (Chaverra-
Rodriguez et al. 2018), andmay be useful in other insect species as well.
In organisms where P2C is not effective in delivery, other ligands may
be identified from proteins intrinsic to that species that are specifically
targeted to the germline. We anticipate that such developments along
with the straight-forward set of modifications for the adaptation to An.
stephensi demonstrated here, will lead to the application of P2C-Cas9
to genetic studies not only to other important malaria vectors, but
also to other species currently recalcitrant to gene editing techniques.
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